SHTDF — Sinopharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual balance sheet for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	43,541	55,327	63,814	56,865	48,796
Net Total Accounts Receivable
Net Total Receivables	176,321	175,787	189,855	206,768	206,652
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	290,922	319,406	336,835	347,448	346,796
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,408	19,647	19,898	19,632	18,229
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	335,412	364,775	383,395	392,831	390,361
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	219,307	234,963	241,491	250,376	246,726
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	273,526	296,707	308,813	313,947	306,408
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	61,886	68,069	74,582	78,884	83,953
Total Liabilities & Shareholders' Equity	335,412	364,775	383,395	392,831	390,361
Total Common Shares Outstanding